Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Mackinnon

Showing results (51-60 of 106) with videos related to

Pageof 11
Sort By:
Hematology (Amsterdam, Netherlands)|July 12, 2008
The outcome of haemopoietic stem cell transplantation in the treatment of lymphoplasmacytic lymphoma in the UK: a British Society Bone Marrow Transplantation studyMaria H Gilleece, Rachel Pearce, David C Linch, et al.
British Journal of Haematology|October 9, 2003
T- and B-cell immune reconstitution and clinical outcome in patients with multiple myeloma receiving T-cell-depleted, reduced-intensity allogeneic stem cell transplantation with an alemtuzumab-containing conditioning regimen followed by escalated donor lymphocyte infusionsShirley D'Sa, Karl Peggs, Arnold Pizzey, et al.
Haematologica|November 4, 2005
The impact of donor factors on primary non-engraftment in recipients of reduced intensity conditioned transplants from unrelated donorsBronwen E Shaw, Nigel H Russell, Steve Devereux, et al.
British Journal of Haematology|January 23, 2010
Cytomegalovirus-specific CD8(+) T cells targeting different HLA/peptide combinations correlate with protection but at different threshold frequenciesSandra Giest, Sarah Grace, Alexandra C Senegaglia, et al.
British Journal of Haematology|November 10, 2009
Cytomegalovirus-specific CD8(+) T cells targeting different HLA/peptide combinations correlate with protection but at different threshold frequenciesSandra Giest, Sarah Grace, Alexandra C Senegaglia, et al.
British Journal of Haematology|July 27, 2005
Conventional second-line salvage chemotherapy regimens are not warranted in patients with malignant lymphomas who have progressive disease after first-line salvage therapy regimensKirit M Ardeshna, Nicholaos Kakouros, Wendi Qian, et al.
Blood|July 19, 2003
Reconstitution of the Epstein-Barr virus-specific cytotoxic T-lymphocyte response following T-cell-depleted myeloablative and nonmyeloablative allogeneic stem cell transplantationSuparno Chakrabarti, Donald W Milligan, Deenan Pillay, et al.
Blood|October 22, 2005
Results of alemtuzumab-based reduced-intensity allogeneic transplantation for chronic lymphocytic leukemia: a British Society of Blood and Marrow Transplantation StudyJulio Delgado, Kirsty Thomson, Nigel Russell, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 27, 2005
Histologic features of the liver biopsy predict the clinical outcome for patients with graft-versus-host disease of the liverRafael F Duarte, Julio Delgado, Bronwen E Shaw, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 27, 2007
High response rate to donor lymphocyte infusion after allogeneic stem cell transplantation for indolent non-Hodgkin lymphomaAdrian J C Bloor, Kirsty Thomson, Noha Chowdhry, et al.
Pageof 11

Showing results (51-60 of 106) with videos related to

Sort By:
Pageof 11
Hematology (Amsterdam, Netherlands)|July 12, 2008
The outcome of haemopoietic stem cell transplantation in the treatment of lymphoplasmacytic lymphoma in the UK: a British Society Bone Marrow Transplantation studyMaria H Gilleece, Rachel Pearce, David C Linch, et al.
British Journal of Haematology|October 9, 2003
T- and B-cell immune reconstitution and clinical outcome in patients with multiple myeloma receiving T-cell-depleted, reduced-intensity allogeneic stem cell transplantation with an alemtuzumab-containing conditioning regimen followed by escalated donor lymphocyte infusionsShirley D'Sa, Karl Peggs, Arnold Pizzey, et al.
Haematologica|November 4, 2005
The impact of donor factors on primary non-engraftment in recipients of reduced intensity conditioned transplants from unrelated donorsBronwen E Shaw, Nigel H Russell, Steve Devereux, et al.
British Journal of Haematology|January 23, 2010
Cytomegalovirus-specific CD8(+) T cells targeting different HLA/peptide combinations correlate with protection but at different threshold frequenciesSandra Giest, Sarah Grace, Alexandra C Senegaglia, et al.
British Journal of Haematology|November 10, 2009
Cytomegalovirus-specific CD8(+) T cells targeting different HLA/peptide combinations correlate with protection but at different threshold frequenciesSandra Giest, Sarah Grace, Alexandra C Senegaglia, et al.
British Journal of Haematology|July 27, 2005
Conventional second-line salvage chemotherapy regimens are not warranted in patients with malignant lymphomas who have progressive disease after first-line salvage therapy regimensKirit M Ardeshna, Nicholaos Kakouros, Wendi Qian, et al.
Blood|July 19, 2003
Reconstitution of the Epstein-Barr virus-specific cytotoxic T-lymphocyte response following T-cell-depleted myeloablative and nonmyeloablative allogeneic stem cell transplantationSuparno Chakrabarti, Donald W Milligan, Deenan Pillay, et al.
Blood|October 22, 2005
Results of alemtuzumab-based reduced-intensity allogeneic transplantation for chronic lymphocytic leukemia: a British Society of Blood and Marrow Transplantation StudyJulio Delgado, Kirsty Thomson, Nigel Russell, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 27, 2005
Histologic features of the liver biopsy predict the clinical outcome for patients with graft-versus-host disease of the liverRafael F Duarte, Julio Delgado, Bronwen E Shaw, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 27, 2007
High response rate to donor lymphocyte infusion after allogeneic stem cell transplantation for indolent non-Hodgkin lymphomaAdrian J C Bloor, Kirsty Thomson, Noha Chowdhry, et al.
Pageof 11